AJMC – Pierce Looks to the Future of Trial Diversity, Reflecting on Current and Historical Barriers
Lori J. Pierce, MD, FASTRO, FASCO, started her session with “the obvious.” The chair of the American Society of Clinical Oncology (ASCO) Board of Directors said, “We know the participation of adult cancer patients on clinical trials in this country is woefully low. “We also know the rate of participation of patients [of racial and…